The French group's sharp slide is the clearest signal yet that high-end spending is cooling, and the sector's biggest players should take note.

Ancient DNA reveals a surprising ritual: teeth deposited in a sacred cave belonged to elites buried in tombs far away, rewriting assumptions about Maya power and burial.

The marketplace is forcing sellers to prove their items are real, targeting AI-generated listings that buyers say they can't identify.

The marketplace's new AI policy targets automated listings and AI-created content, signaling a broader crackdown on generative AI in e-commerce.

The Oculus and Anduril founder is betting $200 million that 'elite working dogs' with advanced body armor will reshape the battlefield.

The streaming giant is tightening household verification, a move that could convert shared-plan discount users into full-price subscribers.

Late-stage win sets up regulatory talks and could reshape how cancer is treated - and how biotech investors value mRNA platforms.

A vulnerability in the code behind a large share of the web is triggering a worldwide scramble to patch, and it's a reminder that your stack's oldest dependencies can be its biggest risk.

Musk's reported stake lands alongside Laurene Powell Jobs as the $111bn Paramount-WBD merger redraws Hollywood.

Vast resources and a huge population still attract capital, but regulatory chaos is pushing executives to look elsewhere.

Europe's Less-Personalized Ads model, live since the start of the year, is now showing up in Meta's earnings - and it is a warning shot for every business built on targeted advertising.

Guardian investigation ties US-made stun guns to abuse of Palestinian detainees, putting Axon's export practices in the crosshairs.